X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse J.B.Chemicals with MYLAN INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs MYLAN (US) - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 J.B.CHEMICALS   MYLAN
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
MYLAN
Dec-14
J.B.CHEMICALS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3183,805-   
Low Rs2002,682-   
Sales per share (Unadj.) Rs148.01,302.8-  
Earnings per share (Unadj.) Rs19.1156.9-  
Cash flow per share (Unadj.) Rs23.9252.6-  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.9647.6-  
Shares outstanding (eoy) m84.82378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x1.72.5 70.2%   
Avg P/E ratio x13.620.7 65.6%  
P/CF ratio (eoy) x10.812.8 84.2%  
Price / Book Value ratio x2.05.0 40.1%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9511,227,273 1.8%   
No. of employees `0002.725.0 10.9%   
Total wages/salary Rs m1,8410-   
Avg. sales/employee Rs Th4,590.919,716.9 23.3%   
Avg. wages/employee Rs Th673.40-   
Avg. net profit/employee Rs Th592.12,375.2 24.9%   
INCOME DATA
Net Sales Rs m12,551492,922 2.5%  
Other income Rs m542-2,873 -18.8%   
Total revenues Rs m13,093490,049 2.7%   
Gross profit Rs m2,055122,592 1.7%  
Depreciation Rs m41236,203 1.1%   
Interest Rs m9621,262 0.5%   
Profit before tax Rs m2,08862,254 3.4%   
Minority Interest Rs m0-255 0.2%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4692,618 17.9%   
Profit after tax Rs m1,61959,381 2.7%  
Gross profit margin %16.424.9 65.8%  
Effective tax rate %22.54.2 534.2%   
Net profit margin %12.912.0 107.1%  
BALANCE SHEET DATA
Current assets Rs m7,778433,344 1.8%   
Current liabilities Rs m4,358338,788 1.3%   
Net working cap to sales %27.219.2 142.0%  
Current ratio x1.81.3 139.5%  
Inventory Days Days5578 70.0%  
Debtors Days Days80107 74.6%  
Net fixed assets Rs m5,713114,036 5.0%   
Share capital Rs m17017,431 1.0%   
"Free" reserves Rs m10,5470-   
Net worth Rs m10,937245,031 4.5%   
Long term debt Rs m0366,052 0.0%   
Total assets Rs m15,574986,961 1.6%  
Interest coverage x22.83.9 581.0%   
Debt to equity ratio x01.5 0.0%  
Sales to assets ratio x0.80.5 161.4%   
Return on assets %11.08.2 134.7%  
Return on equity %14.824.2 61.1%  
Return on capital %20.013.6 146.5%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Net fx Rs m4,8840-   
CASH FLOW
From Operations Rs m1,39764,795 2.2%  
From Investments Rs m-320-51,099 0.6%  
From Financial Activity Rs m-1,196-17,073 7.0%  
Net Cashflow Rs m-102-3,378 3.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 63.85 Rs / USD

Compare J.B.CHEMICALS With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare J.B.CHEMICALS With: UNICHEM LAB  PLETHICO PHARMA  LUPIN LTD  SUN PHARMA  AJANTA PHARMA  



Today's Market

Sensex Trades on a Positive Note; Apollo Micro Systems IPO Lists at 74% Premium(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the energy sector and IT sector witnessing maximum buying interest.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jan 22, 2018 01:53 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS